Nasus Pharma Ltd
NSRX
$3.64
0.00
(0.00%)
at close
4
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome
Analytical Summary
Nasus Pharma Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
11.9x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Sep 23, 2026.
trending_up
Bullish Indicators
- No bullish signals detected.
warning
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Profitability
27
Returns
2
Cash Quality ↓
57
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare NSRX against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare NSRX against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for NSRX
Bullish
0
No bullish signals detected
Bearish
1
Return on Common Equity (%)
-211.6%
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How NSRX compares to all companies
Return on Common Equity (%)
-211.6%
Bottom 25%
Peers: Top 100%
Profit Margin (%)
-0.5%
Bottom 50%
Peers: Top 79%
Operating Margin (%)
-0.4%
Bottom 50%
Peers: Top 82%
Peer Comparison
NSRX vs similar peers
Return on Common Equity (%)
NSRX
-211.6%
#15 of 14
ZTS
80.2%
ALNY
39.8%
ACAD
31.9%
Peer median: 12.49
Profit Margin (%)
NSRX
-0.5%
#15 of 18
UTHR
41.9%
PTCT
39.4%
ACAD
36.5%
Peer median: 9.64
Debt to Equity
NSRX
—
#None of 7
SRPT
0.12x
ONC
0.19x
PBH
0.54x
Peer median: 0.57
Operating Margin (%)
NSRX
-0.4%
#13 of 15
RPRX
65.6%
PTCT
50.1%
UTHR
46.9%
Peer median: 13.05
Compare NSRX with peers
Stack NSRX against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced yesterday 4 years · 4 quarters